Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Bleeding Disorders market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Bleeding Disorders market. Detailed analysis of key players, along with key growth strategies adopted by Bleeding Disorders industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Xenetic Biosciences
Baxter International
Bristol-Myers Squibb Company
Novo Nordisk
Pfizer
Bioverativ
Amgen
Bayer
Alnylam Pharmaceuticals
By Type:
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
By End-User:
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bleeding Disorders Market
-
1.3 Market Segment by Type
-
1.3.1 Japan Bleeding Disorders Market Size and Growth Rate of Plasma-derived Coagulation Factor Concentrates from 2014 to 2026
-
1.3.2 Japan Bleeding Disorders Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates from 2014 to 2026
-
1.3.3 Japan Bleeding Disorders Market Size and Growth Rate of Desmopressin from 2014 to 2026
-
1.3.4 Japan Bleeding Disorders Market Size and Growth Rate of Antifibrinolytics from 2014 to 2026
-
1.3.5 Japan Bleeding Disorders Market Size and Growth Rate of Fibrin Sealants from 2014 to 2026
-
1.3.6 Japan Bleeding Disorders Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
-
1.4.1 Market Size and Growth Rate of Hemophilia A
-
1.4.2 Market Size and Growth Rate of Hemophilia B
-
1.4.3 Market Size and Growth Rate of Von Willebrand Disease
-
1.4.4 Market Size and Growth Rate of Others
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Bleeding Disorders Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bleeding Disorders by Major Types
-
3.4.1 Japan Bleeding Disorders Market Size and Growth Rate of Plasma-derived Coagulation Factor Concentrates from 2014 to 2026
-
3.4.2 Japan Bleeding Disorders Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates from 2014 to 2026
-
3.4.3 Japan Bleeding Disorders Market Size and Growth Rate of Desmopressin from 2014 to 2026
-
3.4.4 Japan Bleeding Disorders Market Size and Growth Rate of Antifibrinolytics from 2014 to 2026
-
3.4.5 Japan Bleeding Disorders Market Size and Growth Rate of Fibrin Sealants from 2014 to 2026
-
3.4.6 Japan Bleeding Disorders Market Size and Growth Rate of Others from 2014 to 2026
4 Segmentation of Bleeding Disorders Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bleeding Disorders by Major End-Users
-
4.4.1 Market Size and Growth Rate of Bleeding Disorders in Hemophilia A
-
4.4.2 Market Size and Growth Rate of Bleeding Disorders in Hemophilia B
-
4.4.3 Market Size and Growth Rate of Bleeding Disorders in Von Willebrand Disease
-
4.4.4 Market Size and Growth Rate of Bleeding Disorders in Others
5 Market Analysis by Regions
-
5.1 Japan Bleeding Disorders Production Analysis by Regions
-
5.2 Japan Bleeding Disorders Consumption Analysis by Regions
6 Hokkaido Bleeding Disorders Landscape Analysis
-
6.1 Hokkaido Bleeding Disorders Landscape Analysis by Major Types
-
6.2 Hokkaido Bleeding Disorders Landscape Analysis by Major End-Users
7 Tohoku Bleeding Disorders Landscape Analysis
-
7.1 Tohoku Bleeding Disorders Landscape Analysis by Major Types
-
7.2 Tohoku Bleeding Disorders Landscape Analysis by Major End-Users
8 Kanto Bleeding Disorders Landscape Analysis
-
8.1 Kanto Bleeding Disorders Landscape Analysis by Major Types
-
8.2 Kanto Bleeding Disorders Landscape Analysis by Major End-Users
9 Chubu Bleeding Disorders Landscape Analysis
-
9.1 Chubu Bleeding Disorders Landscape Analysis by Major Types
-
9.2 Chubu Bleeding Disorders Landscape Analysis by Major End-Users
10 Kinki Bleeding Disorders Landscape Analysis
-
10.1 Kinki Bleeding Disorders Landscape Analysis by Major Types
-
10.2 Kinki Bleeding Disorders Landscape Analysis by Major End-Users
11 Chugoku Bleeding Disorders Landscape Analysis
-
11.1 Chugoku Bleeding Disorders Landscape Analysis by Major Types
-
11.2 Chugoku Bleeding Disorders Landscape Analysis by Major End-Users
12 Shikoku Bleeding Disorders Landscape Analysis
-
12.1 Shikoku Bleeding Disorders Landscape Analysis by Major Types
-
12.2 Shikoku Bleeding Disorders Landscape Analysis by Major End-Users
13 Kyushu Bleeding Disorders Landscape Analysis
-
13.1 Kyushu Bleeding Disorders Landscape Analysis by Major Types
-
13.2 Kyushu Bleeding Disorders Landscape Analysis by Major End-Users
14 Major Players Profiles
-
14.1 Sanofi
-
14.1.1 Sanofi Company Profile and Recent Development
-
14.1.2 Sanofi Market Performance
-
14.1.3 Sanofi Product and Service Introduction
-
14.2 Xenetic Biosciences
-
14.2.1 Xenetic Biosciences Company Profile and Recent Development
-
14.2.2 Xenetic Biosciences Market Performance
-
14.2.3 Xenetic Biosciences Product and Service Introduction
-
14.3 Baxter International
-
14.3.1 Baxter International Company Profile and Recent Development
-
14.3.2 Baxter International Market Performance
-
14.3.3 Baxter International Product and Service Introduction
-
14.4 Bristol-Myers Squibb Company
-
14.4.1 Bristol-Myers Squibb Company Company Profile and Recent Development
-
14.4.2 Bristol-Myers Squibb Company Market Performance
-
14.4.3 Bristol-Myers Squibb Company Product and Service Introduction
-
14.5 Novo Nordisk
-
14.5.1 Novo Nordisk Company Profile and Recent Development
-
14.5.2 Novo Nordisk Market Performance
-
14.5.3 Novo Nordisk Product and Service Introduction
-
14.6 Pfizer
-
14.6.1 Pfizer Company Profile and Recent Development
-
14.6.2 Pfizer Market Performance
-
14.6.3 Pfizer Product and Service Introduction
-
14.7 Bioverativ
-
14.7.1 Bioverativ Company Profile and Recent Development
-
14.7.2 Bioverativ Market Performance
-
14.7.3 Bioverativ Product and Service Introduction
-
14.8 Amgen
-
14.8.1 Amgen Company Profile and Recent Development
-
14.8.2 Amgen Market Performance
-
14.8.3 Amgen Product and Service Introduction
-
14.9 Bayer
-
14.9.1 Bayer Company Profile and Recent Development
-
14.9.2 Bayer Market Performance
-
14.9.3 Bayer Product and Service Introduction
-
14.10 Alnylam Pharmaceuticals
-
14.10.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
14.10.2 Alnylam Pharmaceuticals Market Performance
-
14.10.3 Alnylam Pharmaceuticals Product and Service Introduction
The List of Tables and Figures (Totals 109 Figures and 167 Tables)
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Plasma-derived Coagulation Factor Concentrates from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Desmopressin from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Antifibrinolytics from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Fibrin Sealants from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Market Size and Growth Rate of Hemophilia A
-
Figure Market Size and Growth Rate of Hemophilia B
-
Figure Market Size and Growth Rate of Von Willebrand Disease
-
Figure Market Size and Growth Rate of Others
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Bleeding Disorders Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Bleeding Disorders Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Bleeding Disorders
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bleeding Disorders by Different Types from 2014 to 2026
-
Table Consumption Share of Bleeding Disorders by Different Types from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Plasma-derived Coagulation Factor Concentrates from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Desmopressin from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Antifibrinolytics from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Fibrin Sealants from 2014 to 2026
-
Figure Japan Bleeding Disorders Market Size and Growth Rate of Others from 2014 to 2026
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Bleeding Disorders by Different End-Users from 2014 to 2026
-
Table Consumption Share of Bleeding Disorders by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Hemophilia A
-
Figure Market Size and Growth Rate of Hemophilia B
-
Figure Market Size and Growth Rate of Von Willebrand Disease
-
Figure Market Size and Growth Rate of Others
-
Table Japan Bleeding Disorders Production by Regions
-
Table Japan Bleeding Disorders Production Share by Regions
-
Figure Japan Bleeding Disorders Production Share by Regions in 2014
-
Figure Japan Bleeding Disorders Production Share by Regions in 2018
-
Figure Japan Bleeding Disorders Production Share by Regions in 2026
-
Table Japan Bleeding Disorders Consumption by Regions
-
Table Japan Bleeding Disorders Consumption Share by Regions
-
Figure Japan Bleeding Disorders Consumption Share by Regions in 2014
-
Figure Japan Bleeding Disorders Consumption Share by Regions in 2018
-
Figure Japan Bleeding Disorders Consumption Share by Regions in 2026
-
Table Hokkaido Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Hokkaido Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Bleeding Disorders Consumption Share by Types in 2014
-
Figure Hokkaido Bleeding Disorders Consumption Share by Types in 2018
-
Figure Hokkaido Bleeding Disorders Consumption Share by Types in 2026
-
Table Hokkaido Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Hokkaido Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Hokkaido Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Tohoku Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Tohoku Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Bleeding Disorders Consumption Share by Types in 2014
-
Figure Tohoku Bleeding Disorders Consumption Share by Types in 2018
-
Figure Tohoku Bleeding Disorders Consumption Share by Types in 2026
-
Table Tohoku Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Tohoku Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Tohoku Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Tohoku Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Kanto Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Kanto Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Kanto Bleeding Disorders Consumption Share by Types in 2014
-
Figure Kanto Bleeding Disorders Consumption Share by Types in 2018
-
Figure Kanto Bleeding Disorders Consumption Share by Types in 2026
-
Table Kanto Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Kanto Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Kanto Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Kanto Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Chubu Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Chubu Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Chubu Bleeding Disorders Consumption Share by Types in 2014
-
Figure Chubu Bleeding Disorders Consumption Share by Types in 2018
-
Figure Chubu Bleeding Disorders Consumption Share by Types in 2026
-
Table Chubu Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Chubu Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Chubu Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Chubu Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Kinki Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Kinki Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Kinki Bleeding Disorders Consumption Share by Types in 2014
-
Figure Kinki Bleeding Disorders Consumption Share by Types in 2018
-
Figure Kinki Bleeding Disorders Consumption Share by Types in 2026
-
Table Kinki Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Kinki Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Kinki Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Kinki Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Chugoku Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Chugoku Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Bleeding Disorders Consumption Share by Types in 2014
-
Figure Chugoku Bleeding Disorders Consumption Share by Types in 2018
-
Figure Chugoku Bleeding Disorders Consumption Share by Types in 2026
-
Table Chugoku Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Chugoku Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Chugoku Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Chugoku Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Shikoku Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Shikoku Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Bleeding Disorders Consumption Share by Types in 2014
-
Figure Shikoku Bleeding Disorders Consumption Share by Types in 2018
-
Figure Shikoku Bleeding Disorders Consumption Share by Types in 2026
-
Table Shikoku Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Shikoku Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Shikoku Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Shikoku Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Kyushu Bleeding Disorders Consumption by Types from 2014 to 2026
-
Table Kyushu Bleeding Disorders Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Bleeding Disorders Consumption Share by Types in 2014
-
Figure Kyushu Bleeding Disorders Consumption Share by Types in 2018
-
Figure Kyushu Bleeding Disorders Consumption Share by Types in 2026
-
Table Kyushu Bleeding Disorders Consumption by End-Users from 2014 to 2026
-
Table Kyushu Bleeding Disorders Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Bleeding Disorders Consumption Share by End-Users in 2014
-
Figure Kyushu Bleeding Disorders Consumption Share by End-Users in 2018
-
Figure Kyushu Bleeding Disorders Consumption Share by End-Users in 2026
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Xenetic Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xenetic Biosciences
-
Figure Sales and Growth Rate Analysis of Xenetic Biosciences
-
Figure Revenue and Market Share Analysis of Xenetic Biosciences
-
Table Product and Service Introduction of Xenetic Biosciences
-
Table Company Profile and Development Status of Baxter International
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International
-
Figure Sales and Growth Rate Analysis of Baxter International
-
Figure Revenue and Market Share Analysis of Baxter International
-
Table Product and Service Introduction of Baxter International
-
Table Company Profile and Development Status of Bristol-Myers Squibb Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company
-
Table Product and Service Introduction of Bristol-Myers Squibb Company
-
Table Company Profile and Development Status of Novo Nordisk
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk
-
Figure Sales and Growth Rate Analysis of Novo Nordisk
-
Figure Revenue and Market Share Analysis of Novo Nordisk
-
Table Product and Service Introduction of Novo Nordisk
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bioverativ
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bioverativ
-
Figure Sales and Growth Rate Analysis of Bioverativ
-
Figure Revenue and Market Share Analysis of Bioverativ
-
Table Product and Service Introduction of Bioverativ
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
